Health Condition 1: K70-K77- Diseases of liver
Conditions
Interventions
None listed
Sponsors
University of Kerala
Eligibility
Inclusion criteria
Inclusion criteria: Subjects of either gender with an age group between 18 - 70 years Subjects having elevated liver enzymes panel due to multiple causes like obesity, hyper triglyceridemia, drug induced liver disease etc. Subjects with fluctuating liver enzyme panel due to unknown reasons. Subjects who are willing to sign the informed consent form
Exclusion criteria
Exclusion criteria: Patients with chronic liver diseases Pregnant and lactating women Suspected malignant conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the hepatoprotective effect of LIV-EVER (Punarnava – Boerhavia diffusa L-tablet ) in patients with elevated liver enzyme panel Timepoint: The assessments will be done on done on 0th , 45th and 90th day and the results obtained will be statistically analyzed to evaluate the hepatoprotective effect of trial drug in elevated liver enzyme panels. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the additional therapeutic benefits of LIV-EVER (Punarnava – Boerhavia diffusa L –tablet) in patients with elevated liver enzyme panel. Timepoint: The assessments will be done on done on 0th , 45th & 90th day & the results obtained will be statistically analyzed to evaluate the hepatoprotective effect of trial drug in elevated liver enzyme panels. | — |
Countries
India
Contacts
Public ContactDr Shan Sasidharan
Pankajakasthuri Herbal Research Foundation
Outcome results
None listed